Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Immunological Methods
|
April 7, 2009
Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study
Kelly M Loyet, Rong Deng, Wei-Ching Liang, et al.
Mabs
|
February 5, 2014
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K Leabman, Y Gloria Meng, Robert F Kelley, et al.
Bioanalysis
|
March 29, 2012
A case study on Sema3E-Fc aggregation and assay-dependent differences in quantitation
Daniela Bumbaca, Raymond K Tong, Alexander W Koch, et al.
Assay and Drug Development Technologies
|
May 29, 2004
Substrate capacity considerations in developing kinase assays
Laura E DeForge, Andrea G Cochran, Sherry H Yeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 15, 2010
Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys
Rong Deng, Kelly M Loyet, Samantha Lien, et al.
Journal of Immunological Methods
|
February 7, 2007
Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL
Laura E DeForge, Danny H Shih, Derek Kennedy, et al.
Mabs
|
February 14, 2012
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in mice
Rong Deng, Y Gloria Meng, Kwame Hoyte, et al.
Investigative Ophthalmology & Visual Science
|
August 30, 2012
Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration
Kelly M Loyet, Laura E Deforge, Kenneth J Katschke, et al.
Journal of Immunological Methods
|
September 14, 2010
Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF
Laura E DeForge, Kelly M Loyet, Donnie Delarosa, et al.
Bioanalysis
|
April 21, 2016
Characterization of a sensitive mouse Aβ40 PD biomarker assay for Alzheimer's disease drug development in wild-type mice
Yanmei Lu, Kwame Hoyte, William H Montgomery, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Immunological Methods
|
April 7, 2009
Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study
Kelly M Loyet, Rong Deng, Wei-Ching Liang, et al.
Mabs
|
February 5, 2014
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K Leabman, Y Gloria Meng, Robert F Kelley, et al.
Bioanalysis
|
March 29, 2012
A case study on Sema3E-Fc aggregation and assay-dependent differences in quantitation
Daniela Bumbaca, Raymond K Tong, Alexander W Koch, et al.
Assay and Drug Development Technologies
|
May 29, 2004
Substrate capacity considerations in developing kinase assays
Laura E DeForge, Andrea G Cochran, Sherry H Yeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 15, 2010
Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys
Rong Deng, Kelly M Loyet, Samantha Lien, et al.
Journal of Immunological Methods
|
February 7, 2007
Species-dependent serum interference in a sandwich ELISA for Apo2L/TRAIL
Laura E DeForge, Danny H Shih, Derek Kennedy, et al.
Mabs
|
February 14, 2012
Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in mice
Rong Deng, Y Gloria Meng, Kwame Hoyte, et al.
Investigative Ophthalmology & Visual Science
|
August 30, 2012
Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration
Kelly M Loyet, Laura E Deforge, Kenneth J Katschke, et al.
Journal of Immunological Methods
|
September 14, 2010
Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF
Laura E DeForge, Kelly M Loyet, Donnie Delarosa, et al.
Bioanalysis
|
April 21, 2016
Characterization of a sensitive mouse Aβ40 PD biomarker assay for Alzheimer's disease drug development in wild-type mice
Yanmei Lu, Kwame Hoyte, William H Montgomery, et al.
Page
of 2